ABBISKO-B(02256.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 193.47 million, turned into a loss from a profit YoY

August 24, 2026, ABBISKO-B(02256.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 97.27 million, decreased by 84.11% YoY; Net Profit stood at loss of CNY 193.47 million, turned into a loss from a profit YoY; Profit Attributable to Shareholders stood at loss of CNY 193.47 million, turned into a loss from a profit YoY; Basic Earnings Per Share (EPS) stood at loss of CNY 0.31.
In terms of profitability, ABBISKO-B Gross Profit changed from CNY 612.12 million in the same period last year to CNY 95.51 million in the current period, decreased by CNY 516.61 million; gross profit margin changed from 100% in the same period last year to 98.19% in the current period, decreased by 1.81 percentage points; net profit changed from CNY 328.47 million in the same period last year to loss of CNY 193.47 million in the current period, decreased by CNY 521.94 million; net profit margin changed from 53.66% in the same period last year to -198.91% in the current period, decreased by 252.57 percentage points.
In terms of earnings quality, ABBISKO-B Operating Profit changed from CNY 390.5 million in the same period last year to loss of CNY 179.76 million in the current period, decreased by CNY 570.26 million; Operating Profit Margin changed from 63.79% in the same period last year to -184.81% in the current period, decreased by 248.61 percentage points.
In terms of financial soundness, ABBISKO-B Debt-to-Asset Ratio changed from 8.93% in the same period last year to 19.12% in the current period, increased by 10.19 percentage points; Total Equity changed from CNY 2.223 billion in the same period last year to CNY 2.18 billion in the current period, decreased by CNY 42.46 million; Current Liabilities changed from CNY 206.67 million in the same period last year to CNY 515.02 million in the current period, increased by CNY 308.35 million.
In terms of R&D investment focus, ABBISKO-B R&D Expenses changed from CNY 228.02 million in the same period last year to CNY 246.22 million in the current period, increased by CNY 18.2 million; R&D to Total Revenue Ratio changed from 37.25% in the same period last year to 253.14% in the current period, increased by 215.89 percentage points.
By the close of trading on August 24, 2026, ABBISKO-B(02256) saw a loss of 4.36% in its share price, closing at HKD 9.87. The full-day turnover stood at HKD 9.9 million, with the latest market capitalization at HKD 7.09 billion.

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.